- 英文名称
- Halobetasol propionate
- 分子式
- C25H31ClF2O5
- 分子量
- 484.96
- 中文别名
- 卤贝他索丙酸酯; 丙酸乌倍他索; 乌倍他索丙酸酯; 丙酸卤倍他索; (6Α,11Β,16Β)-21-氯-6,9-二氟-11-羟基-16-甲基-17-(1-氧丙氧基)孕甾1,4-二烯-3,20-二酮; 21-氯-6α,9α-二氟-11β,17α-二羟基-16β-甲基-1,4-妊娠双烯-3,20-二酮17-丙酸酯; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-氯乙酰基)-6,9-二氟-11-羟基-10,13,16-三甲基-3-氧代-6,7,8,9,10,11,12,13,14,15,16,17-十二氢-3H-环戊烷并[a]菲-17-基丙酸酯; ulobetasol propionate; BMY-30056; CGP-14458; Uiobetasol Propionate; Ultravate; 21-chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate; 6 alpha-fluoroclobetasol 17-propionate; Halobetasol; halobetasolpropionate; halobetasol 17-propionate; Miracorten; (6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-Chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate; Halobetasol (propionate)
- 用途
- 生命科学领域,具有抗炎、止痒和收缩血管作用;医药领域,作为局部皮质激素,用于缓解对皮质激素敏感的皮肤炎性和瘙痒病症,以及成人患者斑块型银屑病的治疗。